AI assistant
DIMERIX LIMITED — Capital/Financing Update 2008
Jun 23, 2008
64804_rns_2008-06-23_ff2c5562-4e3b-4d76-9724-b78f84868325.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [234 x 87] intentionally omitted <==
24 June 2008
The Manager Companies ASX Limited 20 Bridge Street Sydney NSW 2000
Dear Sir/Madam
Request for extension to voluntary suspension
Pursuant to ASX Listing Rule 17.2, Sun Biomedical Limited ( SBN ) requests an extension to the voluntary suspension pending the release of an announcement in relation to a proposed capital raising by SBN.
SBN proposes that the voluntary suspension be lifted at the earlier of the announcement or the commencement of trading on 26 June 2008.
SBN is not aware of any reason the voluntary suspension should not be granted.
By order of the Board
==> picture [112 x 19] intentionally omitted <==
==> picture [112 x 19] intentionally omitted <==
Alfonso Grillo Company Secretary
Sun Biomedical Limited ABN 18 001 285 230
Investor Communications
Computershare T: +61 1300 850 505 | F: +61 3 9473 2500 |
ASX:SBN www.sunbiomed.com